Franck Grimaud

Franck Charles Marie Grimaud is the founder of Vivalis SA, founded in 1999, where the title held was President, CEO & Head-Investor Relations from 2010 to 2013.
Current jobs include Director & Deputy Chief Executive Officer at Valneva Usa, Inc. (United States) since 2015; Chief Executive Officer & Director at Atlantic Biotherapies since 2015; Chairman-Governing Board at Pays de la Loire Participations since 2016; Chairman at Syndicat Mixte Atlanpole since 2018; Chairman-Governing Board at Fonds Pays De La Loire Participations since 2016; Director at Valneva Scotland Ltd. since 2017; Co-Managing Director at VALNEVA Austria GmbH since 2013; Director & Managing Director at Vaccines Holdings Sweden AB since 2014; Director at BliNK Biomedical SAS; Director at Valneva Sweden AB since 2015; Director at Valneva UK Ltd. since 2015; Director & President at Valneva Canada, Inc. since 2015; and Chief Business Officer at Intercell Austria AG since 2013.
Former jobs include Chairman at Vivalis Toyama Japan KK from 2013 to 2018; Director at France Biotech Association; President & Managing Director at Smol Therapeutics SAS; Director at Grimaud Deyang Animal Co. Ltd. from 2000 to 2019; Director at Chengdu Grimaud Breeding Co. Ltd. from 2000 to 2018; and Co-President & Chief Business Officer at Valneva SE from 2013 to 2025.
Education includes an MBA from the University of Ottawa.